Skip to main content

hwk-007

·Code: HWK-007

hwk-007: 1 clinical trial tracked.

hwk-007 evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about hwk-007, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 1 study sponsors
Clinical Trial Registry Records (1)

A Phase 1 First-in-Human Study of PTK7-Directed Antibody Drug Conjugate HWK-007 in Participants With Advanced Solid Tumors

NCT07444814Registry updated 2026-08-05·Phase 1·WHWK
Recruiting

Primary endpoint: Determine Maximum Tolerated Dose (MTD)

Interventionalopen226 targetStarted 2025-12Completion 2028-1212 sites · United StatesWhitehawk Therapeutics, Inc.